Special notice: Important policy changes

May 2025Important Notices

Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.

  • Varicose Veins – MP.066 is being retired and will be replaced by Varicose Veins – MP.PA.145.
  • Genetic Testing – Hereditary and Multifactorial Diseases – MP.PA.118 is a new prior authorization policy.

     

  • Laparoscopic Cholecystectomy, 18 Years Old and Older – MP.PA.146 is a new prior authorization policy.

     

  • Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 is a new prior authorization policy.

     

  • Cardiac Ablation Procedures, 18 Years Old and Older – MP.PA.148 is a new prior authorization policy.

Again, prior authorizations will be implemented in accordance with these policies beginning June 1.

If you have any questions or concerns about these policy changes, please contact your physician account executive or call Provider Services at 1-866-918-1595.

Thank you for the excellent care and support you provide to our members.


Recent Announcements

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates